Get the tools used by (smart)2 investors.

Number of Sell Recommendations for Bristol-Myers Squibb Company

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

BMY: Bristol-Myers Squibb Company

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology,...

58.90 USD
Price
USD
Fair Value
Upside
39.35 - 63.33
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Bristol-Myers Squibb Company's Number of Sell Recommendations:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 20240011

Performance Summary
  • Bristol-Myers Squibb's number of sell recommendations is 1

How does Bristol-Myers Squibb's Number of Sell Recommendations benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Bristol-Myers Squibb Company because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Number of Sell Recommendations

Hide this widget
analyst_sell_rec_count
Slug
number
Datatype
text
Format
current
Default Period
D
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Number of Sell Recommendations in the predictions category include:

View Full List

Search for metric or datapoint

Number of Sell Recommendations

The number of analysts publishing a Sell recommendation for the stock.

Definition of Number of Sell Recommendations

Hide this widget
The number of analysts publishing a Sell recommendation for the stock.

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
001105001,0001,5002,000

The chart above depicts the distribution of number of sell recommendations for companies operating in the Healthcare sector in the Developed economic region. Over 2,220 companies were considered in this analysis, and 2,200 had meaningful values. The average number of sell recommendations of companies in the sector is 0 with a standard deviation of 0.

Bristol-Myers Squibb Company's Number of Sell Recommendations of 1 ranks in the 100.0% percentile for the sector. The following table provides additional summary stats:

Number of Sell Recommendations In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,223
Included Constituents2,200
Min0
Max1
Median0
Mean0
Standard Deviation0

You can find companies with similar number of sell recommendations using this stock screener.

All rights reserved. Terms Of Use